"Congrats to Omnica Customer Bardy Diagnostics! The Carnation Ambulatory Monitor is one of six healthcare tech startups chosen from hundreds of submissions to partner with hospitals throughout Arkansas…
Sourced through Scoop.it from: www.dicardiology.com
Agilent Technologies has launched a new analyzer for research work that allows scientists to observe cell behavior and movement in real time while also collecting detailed biosensor information.
Sourced through Scoop.it from: www.fiercebiotech.com
Caesarea, Israel-based V-Wave has received breakthrough device designation for its Interatrial Shunt for heart failure. It is one of several companies this month to receive the designation, which is granted to devices that have the potential to offer a more effective treatment or diagnosis of…
Sourced through Scoop.it from: www.mddionline.com
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Tulsa-Pro for ablation of prostate tissue.
Sourced through Scoop.it from: www.itnonline.com
The test — which uses PCR amplification and electrochemical detection — provides sample-to-answer results in about 30 minutes for the detection of chlamydia and gonorrhea, two highly prevalent sexually transmitted infections, the firm said. The platform uses female vaginal swab samples collected by a clinician or self-collected by a patient in a clinical setting.
Sourced through Scoop.it from: www.360dx.com
GNA Biosolutions raised $13.5 million to support its point-of-care molecular diagnostics platform designed to quickly examine samples taken from whole blood, sputum and nasal swabs.
Sourced through Scoop.it from: www.fiercebiotech.com
Ancora Heart kicked off a European clinical study for its device designed to directly repair an enlarged left ventricle from the inside, as a treatment for patients suffering from heart failure.
Sourced through Scoop.it from: www.fiercebiotech.com
FLUOROspeed X1 is a conventional RF table system offering high image quality and a multitude of features that improve workflow and operator efficiencies.
Sourced through Scoop.it from: www.mpo-mag.com
ExThera, a company based outside of Oakland, California, won European regulatory approval for its Seraph 100 Microbind Affinity Blood Filter.The device…
Sourced through Scoop.it from: www.medgadget.com
AtriCure is set to acquire Redwood City, CA-based SentreHEART in a deal that could cost up to $300 million.
Sourced through Scoop.it from: www.mddionline.com